The role of endothelin-1 in hyperoxia-induced lung injury in mice by Habre, Walid et al.
BioMed  Central
Page 1 of 10
(page number not for citation purposes)
Respiratory Research
Open Access Research
The role of endothelin-1 in hyperoxia-induced lung injury in mice
Walid Habre1, Ferenc Peták*2, Isabelle Ruchonnet-Metrailler3, Yves Donati3, 
Jean-Francois Tolsa4, Eniko Lele2, Gergely Albu1, Morice Beghetti5 and 
Constance Barazzone-Argiroffo3,6
Address: 1Pediatric Anesthesia Unit, Geneva Children's Hospital, University Hospitals of Geneva, 6, Rue Willy Donze, CH-1205, Geneva, 
Switzerland, 2Department of Medical Informatics and Engineering, University of Szeged, Koranyi fasor 9, H-6720, Szeged, Hungary, 3Department 
of Immunology and Pathology, University of Geneva, 1 rue Michel-Servet, CH-1211, Geneva 14, Switzerland, 4Department of Pediatrics, 
University Hospital of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland, 5Pediatric Cardiology Unit, Department of Pediatrics, Geneva 
Children's Hospital, 6, Rue Willy Donze, CH-1205, Geneva, Switzerland and 6Pediatric Pulmonology Unit, Department of Pediatrics, Geneva 
Children's Hospital, 6, Rue Willy Donze, CH-1205, Geneva, Switzerland
Email: Walid Habre - Walid.Habre@hcuge.ch; Ferenc Peták* - petak@dmi.szote.u-szeged.hu; Isabelle Ruchonnet-
Metrailler - Isabelle.Metrailler@medecine.unige.ch; Yves Donati - Yves.Donati@medecine.unige.ch; Jean-Francois Tolsa - Jean.Tolsa@chuv.ch; 
Eniko Lele - leleeni@dmi.szote.u-szeged.hu; Gergely Albu - gergelyalbu@yahoo.com; Morice Beghetti - maurice.beghetti@hcuge.ch; 
Constance Barazzone-Argiroffo - constance.barazzone@hcuge.ch
* Corresponding author    
Abstract
Background:  As prolonged hyperoxia induces extensive lung tissue damage, we set out to
investigate the involvement of endothelin-1 (ET-1) receptors in these adverse changes.
Methods: Experiments were performed on four groups of mice: control animals kept in room air
and a group of mice exposed to hyperoxia for 60 h were not subjected to ET-1 receptor blockade,
whereas the dual ETA/ETB-receptor blocker tezosantan (TEZ) was administered via an
intraperitoneal pump (10 mg/kg/day for 6 days) to other groups of normal and hyperoxic mice. The
respiratory system impedance (Zrs) was measured by means of forced oscillations in the
anesthetized, paralyzed and mechanically ventilated mice before and after the iv injection of ET-1
(2 µg). Changes in the airway resistance (Raw) and in the tissue damping (G) and elastance (H) of
a constant-phase tissue compartment were identified from Zrs by model fitting.
Results: The plasma ET-1 level increased in the mice exposed to hyperoxia (3.3 ± 1.6 pg/ml)
relative to those exposed to room air (1.6 ± 0.3 pg/ml, p < 0.05). TEZ administration prevented
the hyperoxia-induced increases in G (13.1 ± 1.7 vs. 9.6 ± 0.3 cmH2O/l, p < 0.05) and H (59 ± 9
vs. 41 ± 5 cmH2O/l, p < 0.05) and inhibited the lung responses to ET-1. Hyperoxia decreased the
reactivity of the airways to ET-1, whereas it elevated the reactivity of the tissues.
Conclusion:  These findings substantiate the involvement of the ET-1 receptors in the
physiopathogenesis of hyperoxia-induced lung damage. Dual ET-1 receptor antagonism may well be
of value in the prevention of hyperoxia-induced parenchymal damage.
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Background
In many lung diseases, clinicians are faced with the need
to administer high inspired fractions of oxygen to over-
come hypoxemia, although the breathing of oxygen-
enriched air is known to induce alveolar damage and air-
way irritation in animals and humans [1]. Hyperoxia-
induced lung injury is mediated by numerous mediators,
leading to alveolar cell death, alveolo-capillary disruption
and a lung function deterioration [2]. The level of
endothelin-1 (ET-1), a major mediator regulating both
the vascular [3,4] and the airway smooth muscle tone [5-
7], has been reported to be elevated following the expo-
sure of endothelial cells to hyperoxia [8], and also in dif-
ferent in vivo experimental models of acute lung injury
[9,10]. To date, the role of ET-1 has been primarily docu-
mented in cardiovascular diseases, and particularly in pul-
monary hypertension. The discovery of ET-1 receptor
blocking agents is now recognized as a milestone in the
treatment of this latter disease.
Besides being a major mediator regulating the vascular
tone, ET-1 also plays a major role in the regulation of the
airway caliber [6,7,11-14]. Accordingly, the use of ET-1
receptor blockers may also be of promise for the preven-
tion of the deleterious effects of ET-1 on the lungs; in par-
ticular, the effects of the exogenous administration of ET-
1 on the lung function have been successfully inhibited by
the administration of these agents [11,14]. However, the
preventive potential of ET-1 receptor blockers in combat-
ing elevated levels of endogenous ET-1 in the presence of
lung diseases such as hyperoxia-induced lung injury has
not been characterized.
In a murine model of hyperoxia-induced lung injury, we
earlier demonstrated that features of apoptosis and necro-
sis affect alveolar cells [15]. These histopathological
changes are reflected in deteriorated parenchymal
mechanical properties, whereas the airway function is pre-
served [16]. Since ET-1 has been shown to be associated
with the apoptosis of endothelial cells [17] and, similarly
to hyperoxia, it also induces a parenchymal function
impairment [7,11,18], the involvement of this peptide in
the pathogenesis of hyperoxia-induced lung injury may be
anticipated. Thus, we hypothesized that ET-1 is involved
in the lung function deterioration observed following the
exposure of mice to hyperoxia. To test this hypothesis, we
compared naive animals exposed to hyperoxia with those
where to which a dual ETA/ETB receptor blocker, tezosen-
tan (TEZ), had been administered. Moreover, to assess
whether hyperoxia affects the lung responsiveness, we
also set out to characterize the changes in the lung
mechanical response to exogenous ET-1.
Methods
Animal preparations
The measurements were performed on 6- to 8-wk-old
female C57BL/6 mice mice weighing 20–23 g. The proto-
col had been approved by the institutional ethics commit-
tee for animal experiments and by the veterinary office of
the Canton of Geneva. Mice were randomly assigned to
one or other of the following four protocol groups. There
was no statistically significant difference in body weight
between the animals enrolled in the different protocol
groups. Two groups of animals kept in room air (group C,
n = 8) or were exposed to hyperoxia for 60 h (group Hox,
n = 10) were not subjected to ET-1 receptor blockade, dual
ETA/ETB-receptor blocker TEZ was administered continu-
ously for 6 days via an intraperitoneal pump (10 mg/kg/
day) to two other groups of mice, likewise kept in room
air (group CT, n = 6) or exposed to hyperoxia for 60 h
(group HoxT, n = 7). In these latter two groups of mice, an
osmotic intraperitoneal pump implanted under sterile
surgery was used to deliver TEZ at a rate of 1 µl/h from a
10 mg/ml solution in phosphate-buffered saline. The sol-
vent alone was administered in an identical manner to the
animals in the groups C and Hox by performing the surgi-
cal implantation of an identical intraperitoneal pump as
in the groups receiving TEZ. Our previous investigations
led us to expose the mice to 100% oxygen for 60 h in order
to induce marked lung tissue damage without lethal con-
sequences [16].
Hyperoxia was induced by exposure of the animals to
100% oxygen in a sealed (8-liter) Plexiglas chamber under
minimal oxygen inflow and outflow (0.5 l/min). The CO2
level in the box was maintained at 1% by using a CO2
absorber (Drägersorb 800, Dräger Medizintechnik,
Lübeck, Germany). Food and water were available ad libi-
tum. On the day of the experiment, the mice were anesthe-
tized with an intraperitoneal injection of pentobarbital
sodium (50 mg/kg). Tracheostomy was performed, and a
polyethylene cannula (30 mm long, 1.17 mm ID) was
inserted into the trachea. The mice were then mechani-
cally ventilated (model 683, Harvard Apparatus, South
Natick, MA) with a tidal volume of 10 µl/g at a frequency
of 180/min. Muscle paralysis was accomplished through
the intraperitoneal administration of pancuronium bro-
mide (1 mg/kg). To avoid acute hypoxia in the hyperoxic
mice, the animals were kept in 100% oxygen during the
surgical preparation and mechanical ventilation. A femo-
ral vein was cannulated with a 26-gauge catheter for the iv
delivery of ET-1.
Measurement of ET-1 levels in blood
Venous blood samples were collected retroorbitally (200
µl of blood) on EDTA and centrifuged (900 g at room
temperature for 10 min). The separated plasma was stored
at -20°C until assay. The ET-1 level in the plasma was thenRespiratory Research 2006, 7:45 http://respiratory-research.com/content/7/1/45
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determined by an Elisa technique (Human Endothelin
Immunoassay, Catalog number QET00B, R&D Systems
Inc. Minneapolis MN). Reference values were established
from blood samples taken from another group of mouse
identical to those involved in the present study but receiv-
ing no anesthesia or treatment at all.
Forced oscillatory measurements
The forced oscillatory setup for the measurement of respi-
ratory mechanical impedance (Zrs) was described in
detail previously [16,19]. Briefly, a three-way tap (Becton-
Dickinson, model 394600, Helsinborg, Sweden) was used
to switch the tracheal cannula from the respirator to a
loudspeaker-in-box system at end-expiration. A 28-cm-
diameter loudspeaker (250 W) enclosed in a plastic box
served as the pressure generator. The loudspeaker gener-
ated a small-amplitude pseudorandom signal (25 integer-
multiple frequency components between 1 and 25 Hz)
through a 100-cm-long, 1.17-mm-ID polyethylene tube
(Becton-Dickinson, model 6253, Rutherford, NJ). Two
identical pressure transducers (model 33NA002D, ICSen-
sors, Milpitas, CA) were used to measure the lateral pres-
sures at the loudspeaker (P1) and at the tracheal end (P2)
of the wave tube. The P1 and P2 signals were low-pass fil-
tered (5th-order Butterworth, 25-Hz corner frequency)
and sampled with a custom made analog-digital board
(with core components from Analog Devices Inc., Nor-
wood, MA, USA) of a computer at a rate of 256 Hz. Fast
Fourier transformation with 1-s time windows and 90%
overlapping was used to compute the pressure transfer
functions (P1/P2) from the 3-s recordings. The P1/P2 spec-
tra were used to calculate Zrs as the load impedance of the
wave tube [16,19]. Four to six Zrs values were collected in
each mouse for averaging. To avoid possible bias in the
impedance calculation due to the accumulated oxygen in
the wave tube, the oxygen administration was suspended
and the lungs were washed with room air for 30 s before
each recording. Intervals of at least 2 min were interposed
between each two Zrs measurements.
The airway and tissue properties were quantified by fitting
a model to the Zrs spectra under each experimental condi-
tion [11,16,18-20]. The model contained airway resist-
ance (Raw) and inertance (Iaw) in series with the tissue
damping (G) and elastance (H) of a constant-phase tissue
model [20]. Tissue hyteresivity (η) was calculated as η =
G/H [21]. Impedance data at frequencies coinciding with
the heart rate and its harmonics were omitted from the fit-
ting if the cardiac activity caused a low signal-to-noise
ratio at these frequencies and thus, leading to elevations
in the scatter of the Zrs data at these points. The contribu-
tion of the measurement apparatus, including the tracheal
cannula to the reported Raw values, was 0.118 cmH2O.s/
ml.
Study protocol
After surgery, a 10–15-min period was allowed for the
mice to reach a steady-state condition. A deep lung infla-
tion was then performed by superimposing two inpiratory
cycles to standardize volume history. Four Zrs recordings
were then made to establish the baseline. ET-1 at a dose of
2 µg dissolved in 0.1 ml saline was next administered via
the femoral vein to induce lung constriction. Following
ET-1 injection, Zrs was measured at 30 s, and then at 1-
min intervals until 6 min, and at 2 min intervals until 20
min. The Zrs data collected under baseline conditions
were averaged and used for the model fitting. The individ-
ual Zrs data were fitted with the model after the adminis-
tration of the ET-1 challenge.
Statistical analysis
Scatters in the parameters are expressed in SE values. The
plasma ET-1 levels were compared by using the Student t-
test. Two-way repeated measures analysis of variance
(ANOVA) was used, with the administration of TEZ and
ET-1 as the first and second variables, respectively, to
establish the effects of TEZ pretreatment on the respiratory
mechanical parameters under baseline conditions and
following the ET-1 challenge. The Student-Newman-Keuls
multiple comparison procedure was employed to com-
pare the lung mechanical parameters under different con-
ditions. In each test, a significance level of p < 0.05 was
applied.
Results
The plasma ET-1 level was increased significantly (p <
0.05) in the mice exposed to hyperoxia (3.3 ± 1.6 pg/ml,
n = 11) compared with those kept in room air (1.6 ± 0.3
pg/ml, n = 8).
The airway and tissue mechanical parameters obtained
under the control conditions in the four protocol groups
are demonstrated in Fig. 1. In the mice kept in room air,
TEZ decreased Raw and increased G and H significantly (p
< 0.05). In agreement with our previous findings [16],
hyperoxia induced mild, but statistically significant
decreases in Raw (p < 0.05), whereas the tissue resistive
and elastic parameters increased markedly. The hyper-
oxia-induced increases in G and H were significantly
inhibited by TEZ administration. η was not affected by
hyperoxia or TEZ.
The ET-1-induced changes in the airway and tissue
mechanical parameters are depicted in Fig. 2. The ET-1-
induced responses in Raw were greatly influenced both by
the presence of hyperoxia and by TEZ. In the control
group of mice (group C), the administration of ET-1
induced an immediate increase in Raw (129 ± 11% at 30
s), with a subsequent rapid return to the control level (at
2 min). The administration of ET-1 led to significantlyRespiratory Research 2006, 7:45 http://respiratory-research.com/content/7/1/45
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The baseline values of the airway and tissue mechanical parameters obtained in control mice without pretreatment (C), in con- trol mice pretreated with the endothelin receptor blocker tezosentan (CT), and in mice exposed to hyperoxia without pre- treatment (Hox) or with pretreatment with tezosentan (HoxT) Figure 1
The baseline values of the airway and tissue mechanical parameters obtained in control mice without pretreatment (C), in con-
trol mice pretreated with the endothelin receptor blocker tezosentan (CT), and in mice exposed to hyperoxia without pre-
treatment (Hox) or with pretreatment with tezosentan (HoxT). Raw: airway resistance, Iaw: airway inertance, G: tissue 
damping, H: tissue elastance, η: tissue hyteresivity. *: p < 0.05 for the effect tezosentan treatment, #: p < 0.05 vs the parameter 
value obtained in group C.
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Temporal changes in the airway and tissue mechanical parameters after iv endothelin-1 administration Figure 2
Temporal changes in the airway and tissue mechanical parameters after iv endothelin-1 administration. Raw: airway resistance, 
G: tissue damping, H: tissue elastance, η: tissue hyteresivity. *: p < 0.05 vs the baseline value within a group; #: p < 0.05 vs 
group C (control, no tezosentan).
b a s e l i n e 123456 2 0
K
0.0
0.1
0.2
0.3
0.4
time (min)
*
* *
R
a
w
 
(
c
m
H
2
O
.
s
/
m
l
)
0.0
0.2
0.4
0.6
0.8
1.0
1.2 *
*
*
* * * * *
*
*
*
* *
*
*
*
#
#
#
#
#
#
#
*
*
*
G
 
(
c
m
H
2
O
/
m
l
)
0
5
10
15
20
25
30
*
#
#
#
#
* * * * *
* * * * *
*
*
*
#*
*
*
*
#* #*
#* *
H
 
(
c
m
H
2
O
/
m
l
)
0
20
40
60
80
100
*
#
#
* # * #
* #
* #
* # * #
* * * * * * *
* * *
*
* *
*
#
Group C
Group CT
Group Hox
Group HoxT
* * *
#
#
#
#
#
#
#Respiratory Research 2006, 7:45 http://respiratory-research.com/content/7/1/45
Page 6 of 10
(page number not for citation purposes)
smaller increases in Raw in the other three groups of mice
(43 ± 7%, 56 ± 24 and 17 ± 6% in groups Hox, CT and
HoxT at 30 s, respectively), the altered temporal profile
being reflected in a slightly delayed and more sustained
response. As regards the tissue parameters G and H, the
hyperoxia-induced elevation in their baseline values in
group Hox were associated with further marked elevations
in response to ET-1 (41 ± 10% and 33 ± 8% for G and H
at 30 s, respectively), which were maintained until the end
of the study period. TEZ administration not only pre-
vented the elevations in the baseline G and H values, but
also blunted their elevations in response to ET-1, with a
temporal profile similar to that observed in the group C.
Following ET-1 administrations η exhibited significant
increases only in the animals of group C at 30 s, while this
parameter showed no statistically significant changes in
the other groups of mice.
Discussion
The involvement of ET-1 in the hyperoxia-induced lung
function deterioration was characterized in detail in the
present study by assessing the changes in the airway and
tissue mechanics separately following exposure to oxygen
and in response to an exogenous ET-1 challenge in naïve
animals and in mice pretreated with an ET-1 receptor
blocker. Partitioning of the airway and tissue responses
revealed highly dissociated effects of hyperoxia on these
compartments: in the absence of ET-1 receptor blockade,
the hyperoxia-induced mild bronchodilations were asso-
ciated with significantly compromised parenchymal
mechanics. Continuous administration of an ET-1 recep-
tor blocker prevented the deterioration induced by hyper-
oxia in the parenchymal mechanics, while it had no effect
on the airways. Assessment of the airway and tissue
responses following an iv ET-1 challenge also revealed the
contradictory behavior of these compartments: while the
airways displayed a diminished reactivity for this constric-
tor stimulus during hyperoxia, the lung parenchyma
exhibited a significantly enhanced constrictor response.
The Zrs curves and the extracted airway and the tissue
parameters are in excellent agreement with the results of
our earlier report [16], and are consistent with those
obtained by other laboratories in this species under base-
line conditions [22-25]. Furthermore, the hyperoxia-
induced changes in the airway and tissue parameters in
naïve mice are similar to those reported by our group pre-
viously [16], confirming the need for the separate meas-
urement of the airway and tissue mechanical parameters
in order to describe the lung mechanical impairment pre-
cisely under these conditions. Previous studies validating
the reliability of the separation of airway and parenchy-
mal parameters via model-based evaluation of the low-
frequency input impedance spectra revealed that Raw
accurately characterizes the overall airway resistance [26].
Nevertheless, it has also been demonstrated that the tissue
parameters of a single-compartment constant-phase
model may be affected by severe peripheral airway heter-
ogeneities, which may develop in the presence of acute
lung injury [27]. Since heterogeneities are reflected prima-
rily in the elevated η values, and we observed no differ-
ence in this parameter between the protocol groups under
the baseline conditions (Fig. 1), it can be concluded that
hyperoxia induced rather uniform lung damage with no
alterations in the ratio of the energy dissipation to energy
storage in the respiratory tissues. The significant η eleva-
tion observed in Group C 30 seconds after ET-1 injection
suggests that marked ventilation heterogeneities may have
contributed to the marked increases in G obtained in this
group at early stage of the challenge.
It has been now established that, besides its vasoconstric-
tive potential, ET-1 compromises the lung mechanics
[7,11,14,18] and it may therefore play a role in the regu-
lation of the airway tone. Separate assessment of the air-
way and tissue responses to ET-1 in mice previously has
only been achieved by Nagase et al. with the use of alveo-
lar capsules [7]. In contrast with our findings that ET-1
induced primarily an increase in Raw, with a smaller
increase in G and no change in H in the control mice,
Nagase et al. observed similar increases in the airway and
parenchymal mechanical parameters at all ET-1 doses
administered iv to naive animals. Besides the substantial
difference in lung configuration due to the chest opening
[28], further methodological differences between the
studies may explain this discrepancy. Nagase et al. esti-
mated the airway and tissue responses to ET-1 by measur-
ing local alveolar pressures. Nevertheless, the gluing of
alveolar capsules with a diameter comparable to the ster-
nocostal area of the lungs will not only certainly influ-
ences the reliability of airway-tissue separation, but also
probably biases the estimation of the overall lung
mechanics. Further, sampling of one or two alveolar
regions, as performed previously [7], in inhomogenously
constricted lungs [19] makes the capsule-based partition-
ing highly incidental [29].
The literature data regarding the effects of hyperoxia on
the responsiveness of the airways to exogenous constrictor
stimuli are somewhat conflicting. Oxygen exposure has
been reported to have no effect on the bronchial reactivity
[30-32], to enhance the responsiveness of the airways [33-
36] and even to reduce the contractile responses of the
bronchi [37] to exogenous constrictor agonists stimulat-
ing the muscarinic receptors. Many factors may contribute
to this situation. The degree of maturity of the experimen-
tal animals has been suggested to influence the airway
reactivity, with immature rodents being more hyperreac-
tive than adults [31,35-37]. The involvement of different
mediators released by the inflammatory cells followingRespiratory Research 2006, 7:45 http://respiratory-research.com/content/7/1/45
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hyperoxia may also have an impact on the lung responses
to exogenous stimuli [31]; these effects are found to be
diminished in in vitro studies [31,33]. The results of the
present study indicate that the methodological differences
between the techniques used to assess the airway reactivity
are the most likely explanation of this controversy.
All of the in vivo previous studies describing changes in the
bronchial reactivity in various experimental models of
hyperoxia measured overall parameters, such as the total
respiratory [34-36] or pulmonary system resistance
[30,32], to characterize the mechanical changes in the
lungs. These mechanical parameters incorporate the flow
resistance of the airways and the dissipative properties of
the tissues [7,11,15,16,18-20,28,29]. Hence, dissociated
changes in these components cannot be identified, since
any change in tissue dissipation mask those in the airway
properties. Accordingly, opposite changes in these com-
ponents blunt those in the overall parameters, or they
may even be totally extinguished if they are opposite and
equal in magnitude. Our results demonstrate the presence
of such opposite changes in the responsiveness of the air-
way and tissue compartments in the presence of oxygen
toxicity. Indeed, expression of the hyperoxia-induced
changes in the ET-1-responsiveness via calculation of the
total respiratory system resistances at the breathing fre-
quency (Rrs = Raw + G/ωα, where ω = 4π at 2 Hz and α =
2/π arctan [H/G]) in Fig. 3 may lead to misinterpretation
of the lung responses to contrictor stimuli. In fact, the
apparent hyperreactivity of the lung is attributed to the
presence of the enhanced responsiveness of the lung
parenchyma and not to the elevated reactivity of the air-
ways. As far as we are aware, this is the first in vivo study
that has established the changes in the airway and tissue
mechanics separately following a constrictor challenge
during hyperoxia. The fact of the opposite changes in the
Temporal changes in the total respiratory system resistance at 2 Hz after iv endothelin-1 administration Figure 3
Temporal changes in the total respiratory system resistance at 2 Hz after iv endothelin-1 administration. *: p < 0.05 vs. the 
baseline value within a group; #: p < 0.05 vs group C (control, no tezosentan).
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altered reactivity of the airways and the respiratory tissues
emphasizes the need for a separate assessment of the
mechanical responses in these compartments, and also
indicates that previous results should be interpreted with
some caution.
The underlying mechanism responsible for the opposite
changes in the airway and the tissue reactivity to ET-1 fol-
lowing hyperoxia is not completely clear. ET-1 generates
its effect by stimulating both ETA and ETB receptor sub-
types. The antagonism of the ETA receptors inhibits the
ET-1-induced contraction in parenchymal strips, whereas
this treatment is ineffective in isolated bronchi [38], indi-
cating that the antagonist ETA receptors are expressed in
greater density in the lung parenchyma, while the ETB
receptors are expressed more markedly in the airways.
Indeed, autoradiographic studies have revealed the pre-
dominance of the ETB receptors in the trachea in mice
[39]. The different distributions of the receptor subtypes is
of importance, since lung inflammation has been demon-
strated to decrease the density of the ETB receptors [39]
and to increase that of the ETA receptors [40]. Since hyper-
oxia also leads to lung inflammation, it is possible that the
diminished airway responses are due to the decreased
density of the ETB receptors, whereas the enhanced paren-
chymal responsiveness may be attributed (at least in part)
to the upregulation of the ETA receptors in the lung tissue.
In the present study, a dual ETA/ETB receptor blocker was
applied to establish the involvement of ET-1 in hyperoxia-
induced lung damage. The changes in the quantities of the
specific receptors in this process requires the development
of specific ET-1 receptor antibodies to visualize the altered
distributions of the ETA and ETB receptors after hyper-
oxia. Although the application of specific receptor block-
ers in future studies may confirm the involvement of such
a mechanism, the results of such experiments will furnish
only limited information concerning the alterations in the
quantities of the different receptor subtypes in response to
hyperoxia.
Similarly to hyperoxia, TEZ also exerted dissociated effects
on the airway and tissue compartments. It is noteworthy
that in the naïve animals, the blocking of the ET-1 recep-
tors with TEZ decreased the baseline Raw. This suggests
the presence of a basal tone in the bronchial smooth mus-
cle supplied by ET-1. Furthermore, TEZ reproduced the
effects of hyperoxia on the airways (Fig. 1) in the naïve
animals, confirming the involvement of ET-1 in the air-
way effects of hyperoxia. As regards the tissue mechanical
parameters, the most noteworthy finding in the present
study is the ability of TEZ to prevent the impairment
induced in the lung parenchyma by hyperoxia. Numerous
studies have demonstrated the involvement of ET-1 in var-
ious lung diseases that affect the airways [41] or the lung
parenchyma [42]. The results of the present study provide
evidence of the involvement of this peptide in hyperoxia-
induced lung tissue damage. Moreover, ET-1 has been
shown to have proinflammatory properties [43,44] and to
promote edema development [43]. The current findings
additionally demonstrate that blockade of the ETA and
ETB receptors inhibits the proinflammatory activity of ET-
1, which explains the efficiency of TEZ in protecting
against hyperoxia-induced parenchymal mechanical
impairments. The beneficial effects of TEZ against hyper-
oxia accord with the results of recent investigations reveal-
ing its preventive properties against the ET-1-induced
increase in extravascular lung water [9], and the value of
TEZ in the treatment of acute lung injury under experi-
mental conditions in larger mammals [9,45] and in mice
[46].
Conclusion
In summary, the results of the present study yield evidence
of the involvement of ET-1 in the lung function changes
induced by hyperoxia. The highly dissociated effects of
oxygen toxicity on the airway and tissue mechanics dem-
onstrate the need for a separate assessment of the mechan-
ical properties of these compartments in order to describe
the alterations in the respiratory system accurately, and to
design appropriate therepeutic strategies. The separate
measurement of the airway and tissue responses revealed
that, while hyperoxia induces a diminished reactivity of
the airways to ET-1, the lung parenchyma exhibits a signif-
icantly enhanced constrictor response. Blockade of the ET-
1 receptors by tezosentan prevented the lung tissue dam-
age induced by hyperoxia. This demonstrates the key role
of ET-1 in the lung damage evoked by oxygen toxicity, and
suggests potential new perspectives for efficient preven-
tion of the deleterious effects of hyperoxia on the lungs.
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